OPEN END TURBO BULL OPTIONSSCHEIN - BIONTECH ADR Share Price

Certificat

DE000HW0EL62

Real-time Boerse Frankfurt Warrants 09:46:45 30/04/2024 BST
3.37 EUR -1.75% Intraday chart for OPEN END TURBO BULL OPTIONSSCHEIN - BIONTECH ADR
Current month-9.02%
1 month-9.02%
Date Price Change Volume
30/04/24 3.37 -1.75% 0
29/04/24 3.43 +4.57% 0
26/04/24 3.28 +1.55% 0
25/04/24 3.23 -3.87% 0
24/04/24 3.36 0.00% 0

Real-time Boerse Frankfurt Warrants

Last update April 30, 2024 at 09:46 am

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying BIONTECH SE
IssuerLogo Issuer UniCredit UniCredit
WKN HW0EL6
ISINDE000HW0EL62
Date issued 15/05/2020
Strike 52.96 $
Maturity Unlimited
Parity 9.87 : 1
Emission price 0.4
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 35.6
Lowest since issue 0.001
Spread 0.04
Spread %1.19%

Company Profile

BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.
Sector
-
More about the company

Ratings for BioNTech SE

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: BioNTech SE

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
82.08 EUR
Average target price
106.6 EUR
Spread / Average Target
+29.85%
Consensus